Core Insights - Caring Brands Inc. has entered into an exclusive worldwide license agreement with Itonis Inc. to manufacture, market, and distribute Emesyl, an OTC nausea relief product, which provides Caring Brands with full commercialization rights [1][2] Company Overview - Caring Brands Inc. has a growing portfolio of unique, patented, and clinically validated products for skin and hair growth, with plans to launch a total of 5 products over the next 2 years [5] - The company has a successful track record in strategic acquisitions, rapid product development, intellectual property development, and product licensing [5] Market Context - The global market for nausea treatment and related therapies is projected to exceed USD 6.23 billion in 2025, highlighting the commercial potential for the Emesyl license [3] Agreement Details - Under the agreement, Caring Brands will handle product manufacturing, marketing, sales strategy, and global distribution, while Itonis will provide necessary technical and historical sales information [2] - The agreement includes a royalty structure based on future net sales and the potential for Caring Brands to earn equity in Itonis tied to revenue milestones [4]